Your browser doesn't support javascript.
loading
Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial.
Tardif, Jean Claude; Pfeffer, Marc A; Kouz, Simon; Koenig, Wolfgang; Maggioni, Aldo P; McMurray, John J V; Mooser, Vincent; Waters, David D; Grégoire, Jean C; L'Allier, Philippe L; Wouter Jukema, J; White, Harvey D; Heinonen, Therese; Black, Donald M; Laghrissi-Thode, Fouzia; Levesque, Sylvie; Guertin, Marie Claude; Dubé, Marie Pierre.
Afiliação
  • Tardif JC; Department of Medicine, Montreal Heart Institute, Université de Montréal, 5000 Belanger Street, Montreal, PQ, H1T1C8Canada.
  • Pfeffer MA; Beaulieu-Saucier Pharmacogenomics Centre, Université de Montréal, Montreal, Canada.
  • Kouz S; The Montreal Health Innovations Coordinating Center (MHICC), Montreal, Canada.
  • Koenig W; Department of Medicine, The Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Maggioni AP; Department of Medicine, Centre Hospitalier Régional de Lanaudière, Joliette, Canada.
  • McMurray JJV; Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
  • Mooser V; German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany.
  • Waters DD; Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany.
  • Grégoire JC; ANMCO Research Center, Florence, Italy.
  • L'Allier PL; Department of Medicine, British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
  • Wouter Jukema J; Department of Medicine, McGill University, Montreal, Canada.
  • White HD; Division of Cardiology, San Francisco General Hospital.
  • Heinonen T; Department of Medicine, Montreal Heart Institute, Université de Montréal, 5000 Belanger Street, Montreal, PQ, H1T1C8Canada.
  • Black DM; Department of Medicine, Montreal Heart Institute, Université de Montréal, 5000 Belanger Street, Montreal, PQ, H1T1C8Canada.
  • Laghrissi-Thode F; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Levesque S; Netherlands Heart Institute, Utrecht, The Netherlands.
  • Guertin MC; Department of Medicine, Durrer Center for Cardiovascular Research, Amsterdam, The Netherlands.
  • Dubé MP; Green Lane Cardiovascular Unit, Auckland City Hospital, University of Auckland, New Zealand.
Eur Heart J ; 43(39): 3947-3956, 2022 10 14.
Article em En | MEDLINE | ID: mdl-35856777
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acidente Vascular Cerebral / Síndrome Coronariana Aguda / Parada Cardíaca / Anticolesterolemiantes / Infarto do Miocárdio Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acidente Vascular Cerebral / Síndrome Coronariana Aguda / Parada Cardíaca / Anticolesterolemiantes / Infarto do Miocárdio Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article